Clinical trial
What Factors Area Associated With Prognosis After Steroid Hydrodilatation for Adhesive Capsulitis
NCT03622853 is registered in ClinicalTrials.gov with Taipei Veterans General Hospital, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- What Factors Area Associated With Prognosis After Steroid Hydrodilatation for Adhesive Capsulitis
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2018
- Completion date
- March 1, 2019
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adhesive capsulitis